What I don't understand is why you think verbatim repetition of something unsupported is not childish and a waste of bandwidth.
Let's do baby steps then: Is testosterone restrictively metabolized or not? If not then please provide compelling evidence to contradict the references in my post on the subject. Once you concede that metabolism is restrictive then the independence of free testosterone from SHBG falls out. Even the mini ChatGPT can understand this:
AI when asked to comment about magnesium and SHBG binding:
Magnesium binds to sex hormone-binding globulin (SHBG) in a nonspecific manner, which can inhibit the binding of testosterone to SHBG, thereby increasing the availability of bioactive testosterone. This interaction may enhance the levels of free testosterone in the body.
This is the misleading answer you're blindly relying on.
Comment to AI:
This reasoning holds only under transient conditions. It is incorrect if you accept that testosterone is restrictively metabolized. The latter means that clearance of free testosterone is proportional its concentration. With this it falls out that at a steady state free testosterone is proportional to the production rate of testosterone—or its dose rate under TRT—and must be relatively independent of SHBG, negating assertions about magnesium's influence.
AI:
You're correct — under the restrictive (or flow‑limited) clearance assumption your argument is valid.
Brief, focused reply:
- If free testosterone (FT) clearance is first‑order and proportional to FT concentration (restrictive metabolism), steady‑state FT = production rate / clearance constant. That makes steady‑state FT independent of the reversible binding equilibrium with SHBG (assuming binding/unbinding is fast relative to clearance and total binding capacity isn't exhausted).
- In that regime, shifts in SHBG (or nonspecific competitors like Mg2+ that transiently alter binding) change the transient partitioning between bound and free T but not the long‑run steady‑state FT for a fixed production/dose rate.
Comment to AI:
Further, is there any evidence suggesting that free testosterone should not generally be modeled as restrictively metabolized?
AI:
Short answer: No strong general evidence contradicts modeling free testosterone (FT) as restrictively metabolized in many contexts — clearance of circulating FT is largely flow‑limited/first‑order (hepatic uptake and metabolic conversion scale with plasma free concentration), so steady‑state FT tends to track production/dose rather than reversible binding to SHBG. National Institutes of Health Wikipedia
Supporting points:
- Classic isotope‑dilution and clearance studies report high testosterone metabolic clearance rates and treat removal as a first‑order process proportional to circulating (unbound) T, consistent with restrictive (flow‑limited) kinetics. National Institutes of Health
- Reviews and pharmacokinetic summaries describe rapid plasma half‑life and hepatic metabolism as primary determinants of testosterone disposition, with >97% protein binding but clearance dominated by metabolic removal of free hormone. Modeling and clinical TRT literature therefore often assume first‑order clearance of free T. Wikipedia
- Pharmacokinetic principles: when tissue/hepatic extraction is flow‑limited, unbound concentration drives uptake and elimination; reversible plasma protein binding then affects transient free fraction but not steady‑state free level for a fixed input rate unless binding changes also alter clearance mechanisms or total capacity.
Caveats (brief):
- Some situations (very high SHBG changes, altered hepatic function, drugs that change metabolic pathways or transporter activity, or saturable metabolism at very high concentrations) can make clearance deviate from simple first‑order behavior; in those cases FT can depend on binding.ScienceDirect
- Empirical studies sometimes report variable effects of SHBG‑altering interventions on measured FT,likely reflecting assay differences, transient kinetics, or altered metabolism. MDPI
Overall: treating FT as restrictively (first‑order) cleared is a reasonable default supported by physiology and pharmacokinetic studies, but context‑specific exceptions exist.
Comment to AI:
In view of this, comment on someone's statement that "Magnesium supplementation can increase free testosterone levels by binding to Sex Hormone-Binding Globulin (SHBG), reducing its ability to lock up testosterone."
AI:
That statement is misleading.
Brief points:
- Transient effect: Magnesium can competitively or nonspecifically interfere with SHBG binding, so it may temporarily raise free testosterone (FT) shortly after a perturbation.
- Steady state under restrictive clearance: If FT clearance is flow‑limited (clearance ∝ FT), steady‑state FT equals production/dose divided by the clearance constant and is largely independent of reversible binding to SHBG. In that regime, changing SHBG binding (or adding a nonspecific competitor like Mg2+) alters transient partitioning but not long‑term steady‑state FT.
- Measured vs. physiological change: Assay timing and method can show apparent FT changes from altered binding even when physiologic steady‑state FT is unchanged.
- Biological caveats: If binding changes affect clearance pathways (e.g., by changing hepatic uptake) orthere are large changes in total testosterone or SHBG capacity, steady state can be affected; otherwisethe effect is likely minimal and transient.
Conclusion: The claim is only correct for short‑term or measurement effects; it is not generally true that magnesium supplementation chronically raises physiologic free testosterone by binding SHBG.
Question to AI:
Given how the body regulates serum magnesium, are any significant transient effects expected on SHBG binding with typical supplementation doses?
AI:
Short answer: Unlikely — typical oral magnesium supplementation probably produces at most very small, short‑lived changes in SHBG binding that are physiologically negligible.
Why:
- Serum Mg2+ is tightly regulated (kidney reabsorption/excretion, bone exchange). Oral supplementation usually raises serum ionized Mg only modestly and transiently unless deficiency or high doses/IV administration are involved.
- SHBG–ligand interactions are concentration‑dependent; to meaningfully displace testosterone from SHBG you would need a competitor present at a sufficiently high molar concentration or with much higher affinity than physiological Mg2+. Measured free Mg2+ changes after usual oral doses are small compared with protein and steroid concentrations, so the competitive effect is minimal.
- Any small displacement would be transient (minutes–hours) and likely corrected by redistribution, renal excretion, and clearance of free testosterone; at steady state, restrictive clearance implies no lasting increase in free testosterone for a fixed production/dose.
- Exceptions where an effect might be detectable: severe hypomagnesemia corrected rapidly, very largeIV Mg boluses, substantial changes in SHBG concentration or hepatic clearance, or assay artifacts measuring FT shortly after supplementation.
Practical implication: For typical oral supplementation in people with normal Mg status, you should not expect meaningful or sustained increases in physiologic free testosterone via SHBG displacement.
And just to rub it in a little:
Ok, then you agree that your original answer is misleading, because while the Mg/SHBG binding is of academic interest, it has little practical application for people looking to improve free testosterone?
AI:
Yes — I agree. The Mg–SHBG interaction is mechanistically valid but, given homeostatic control of serum Mg and restrictive clearance of free testosterone, it is unlikely to produce meaningful or sustained increases in physiologic free testosterone for people using typical oral supplementation.
If you're still here Vince, I admit I asked the AI some leading questions, but I think if you do the same you still won't get support for the original claim as long as restrictive metabolism and other real-world conditions are entered into evidence. The lesson is that interesting research results do not necessarily translate into something immediately useful and actionable.
